NEC’s AI Approach to Aid BostonGene’s Analytics in Cancer Trials
BostonGene Corporation (BostonGene), a biomedical software company focused on defining optimal precision medicine-based therapies for cancer patients, and NEC Corporation (NEC; TSE: 6701), a leader...